Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by InitiumMMXXIIIon Dec 03, 2023 1:14pm
202 Views
Post# 35765929

Purpose

Purpose
Just to make it clear, the purpose for my two recent posts about a 16 year-old family member dying from glioblastoma has been to express my opinion that, if xB3 works as hoped, then mismanagement of Bioasis may have had and may continue to have grave consequences for sufferers of CNS disorders. But note this; the brain tumour in our family member’s case was so advanced before diagnosis, and was so aggressive, that successful treatment may have been impossible. DrDR and RH should be held responsible for the failure of Bioasis but not for individual, isolated, and anecdotal illnesses.
 
It is also a purpose of mine to keep this Bioasis mess alive, to continue holding management responsible for whatever went wrong, whether it was and remains mismanagement, personal greed or just plain laziness to do the hard things. 
 
A search for sympathy on my part, as posited by TheTruth1234, is ridiculous. This is a stock forum. It’s also 2023. It goes with the territory that any kind of public statement made on any of social media will be attacked by people like TT and beenthere. They have nothing else to offer but trolling and they know it. beenthere is a victim, and appears devoid of any sense of responsibility for his own situation, which is a trait of narcissists. TheTruth1234 is obsessed with me. You can see him trying to come up with new insults about me but he can’t. He just makes the same posts over and over, thinking with each that he’ll get different results. 
 
I do sympathize with beenthere for his losses, as I do for my own and those of all Bioasis shareholders, but many of us lost far more than beenthere has.
 
I will continue to post, occasionally, until all vestiges of Bioasis, xB3, and DrDR disappear from public view. There is news yet to come out about all of this, most likely that Rathjen will sell xB3, and, in some form, will walk away from Bioasis with more than any of us ever got out of it.
 
jd
<< Previous
Bullboard Posts
Next >>